The Daily from Ball State Unified Media
COVID-19

Ball State reports 17 positive COVID-19 cases

<p>This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19). <strong>CDC, Photo Courtesy</strong></p>

This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19). CDC, Photo Courtesy

Ball State reported 17 positive COVID-19 cases among students and employees Feb. 21-27, according to the Ball State COVID-19 dashboard.

Cases continue to drop for the fifth week in a row. This is a 26.1 percent decrease from the Feb. 14-20 positive case count, which was 23.

This continuing drop in cases comes as the Centers for Disease Control and Prevention (CDC) announced a relaxed mask mandate for nearly 70 percent of the country Feb. 25. As of Feb. 28, Delaware County still has a high community level, meaning the CDC recommends wearing a mask indoors.

Campus vaccination rates for full- and part-time employees stayed at 74 percent. This number indicates all those faculty, professional, service and staff employees who are fully vaccinated. Ball State does not currently publicly report the number of students who have received their full vaccination series.

People ages 5 and older are eligible to receive a COVID-19 vaccine. Everyone ages 12 and older are eligible for a Pfizer booster shot at least five months after their second dose, and adults ages 18 and older are eligible for a Moderna shot at least five months after their second dose. Those ages 18 and older who received the Johnson & Johnson vaccine are eligible for a second dose at least two months after their first.

If you have not yet received your COVID-19 vaccine, you can find a vaccination location near you and sign up for an appointment at ourshot.in.gov.

Read More

Comments

More from The Daily

Connect with The Daily

Sponsored Stories

More from our partners

This Week's Digital Issue

Loading Recent Classifieds...